Tags |
|
|
Links |
|
|
Main Subject - Just As Heart Ailment Is A Major Killer, Competition Is The Silent Killer
The management mantra of the 1980s was product quality, and activities involving
Quality Control (QC) circles, Total Quality Management (TQM) and ISO 9000 were the
order of the day.
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
Back then, consumers were willing to spend enormous sums for quality
products. However, product quality has significantly improved and today having a good
quality product is a mandat
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ry requirement for the company’s effective participation and
survival in the marketplace.
Subsequently, the management slogan in the 1990s embraced technology as the cure-all. Compa
Subsequently, the management slogan in the 1990s embraced technology as the cure-all. Compa
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
ies then tried to distinguish themselves from their competitors through the use of
technology, by offering better and more sophisticated features, use of the Internet and
communicati
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
on systems. Huge sums were channelled into technology to build a better
mousetrap with more superior state-of-the-art features. Today, the world does not beat
down the door of the be
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ter mousetrap developer. The collapse of the high tech stocks on
Nasdaq in the early part of 2001 illustrates the vulnerability of technology.
The thrust in the new millennium is comp
The thrust in the new millennium is comp
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
tition. Competition intensifies with the
emergence of a better range of products that are often of superior quality coupled with
attractive and affordable pricing. In such a scenario
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
, many products become marginalized,
and like commodities, pricing becomes a key determinant in a shrinking market.
In today’s competitive environment, your margins for errors are als
In today’s competitive environment, your margins for errors are als
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
thinner. In the past,
three strikes or major mistakes and you are out, but today, one strike or major mistake
and you are history. Customers have many choices and they will switch t
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
eir suppliers at
the turn of the dime if you make a major error in quality, delivery, etc.
Oftentimes, the elusive competition quietly sneaks in by the back door. You may have been
Oftentimes, the elusive competition quietly sneaks in by the back door. You may have been
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
osing trickles of disgruntled customers and one day, you come to the sudden
realisation that even your major customers are gone.
PSA Corporation learnt too late to retain its number o
PSA Corporation learnt too late to retain its number o
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
ne customer, Maersk from
switching to Port of Tanjong Pelepas in Johore. After PSA Corporation rejected the
requests for better terms of AP Moller Group, parent of Maersk Sealand, th
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
world’s
largest operator of container ships, the Copenhagen based company moved the operations
to Tanjong Pelepas and also took a stake in the port. This was a double whammy for
P
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
A Corporation as it not only lost its biggest customer, it has to compete against its
former ally. With the help of Maersk, Tanjong Pelepas is able to capture Evergreen, PSA
Corporat
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ion’s second largest customer. . PSA had tried to compete on efficiency and fast
turnaround of clients’ ships. But this could only justify for some price premium for up to
a point. C
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
nsequently, PSA Corporation has to downsize in order to stay competitive, a
tad too late as it has lost its top two customers within a short period.
Competition may lead to opening up
Competition may lead to opening up
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
new markets. For instance, with the advent of the
low budget airlines, more poor Indonesians are also able to travel overseas. This is the
market segment, which most major airlines s
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
uch as Singapore Airlines will ever wish to
target. But one should never under estimate or take the competition for granted.
Competition is a silent and sudden killer like heart attac
Competition is a silent and sudden killer like heart attac
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
, it can creep up on you without
warning. However, just as an individual can prevent this disease by adopting a healthy
lifestyle, a company can stave off competition by remaining al
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
rt and adopting
appropriate strategies to combat it. When you are faced with increasing competition, you
may still survive, prosper and succeed, but it is no longer business as usual
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/13994/mainsubjects-Just-As-Heart-Ailment-Is-A-Major-Killer-Competition-Is-The-Silent-Killer.html">Just As Heart Ailment Is A Major Killer, Competition Is The Silent Killer</a>
BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/13994/mainsubjects-Just-As-Heart-Ailment-Is-A-Major-Killer-Competition-Is-The-Silent-Killer.html]Just As Heart Ailment Is A Major Killer, Competition Is The Silent Killer[/url]
Related Articles:
Wholesale Distribution Business: What Is Direct Store Delivery?
Are Funeral Escorts Real Cops?
Bookmark it:
|